Enzon Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Jun 23 | BuyUS$13,909 | Randolph Read | Individual | 99,550 | US$0.14 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 633,264 | 0.853% |
Private Companies | 2,043,024 | 2.75% |
Individual Insiders | 5,367,666 | 7.23% |
General Public | 30,114,013 | 40.6% |
Institutions | 36,056,636 | 48.6% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
36,056,636 | US$2.7m | 0% | 0.03% | |||
5,067,666 | US$380.1k | 0% | no data | |||
2,043,024 | US$153.2k | 0% | no data | |||
633,264 | US$47.5k | 0% | no data | |||
200,000 | US$15.0k | 0% | no data | |||
100,000 | US$7.5k | 0% | no data |